TIRZEPATIDE 5MG is a premium research peptide commonly studied for its potential role in metabolic and body-composition research. Research interest centres on GLP-1 and GIP receptor signalling, appetite regulation, glucose control, and body weight.
How it works
Tirzepatide is a dual GLP-1 and GIP receptor agonist studied for its combined incretin action on satiety signalling and glucose regulation.
Key benefits
Supports metabolic research
May support appetite regulation studies
Investigated as a dual incretin agonist
Supports glucose control research
Studied in body weight models
Usage and safety
Product type: Research peptide
Vial size: 5mg
Suggested use: For research use only or as directed by a qualified professional
Storage: Keep in a cool, dry place away from direct sunlight. Refrigerate after reconstitution.
Warnings: For research use only. Not intended for human consumption, medical use, or to diagnose, treat, cure, or prevent any disease.
